BridgeMD
New treatment option for Low Vision
Official title Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision
ClinicalTrials.gov ID: NCT06107881
What this study is testing
- What it's testing
- One goal of this research is to conduct a non-inferiority trial of telerehabilitation versus in-office care to provide follow-up training to individuals with low vision to enhance their quality of life by using magnification devices and/or visual assistive mobile apps for important daily activities, such as reading and/or other valued tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, which can be essentially eliminated with telerehabilitation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- adults with any level of vision loss due to any ocular disease who are age 18 and older, and who have received new magnification device(s) for the...
You likely can't join if
- schedules not permitting participation in planned study visits (including planning to move far from their clinical provider's office within the first...
- inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (greater than mild cognitive impairment as...
- substance abuse,
- significant hearing loss (unable to hear communication by phone or via videoconferencing),
- significant medical condition likely to limit participation or lifespan,
- individuals who require other types of LVR training or intervention (e.g., psychosocial).
See the full eligibility criteria
- adults with any level of vision loss due to any ocular disease who are age 18 and older, and who have received new magnification device(s) for the first time (i.e., hand-held optical magnifiers, portable electronic...
- schedules not permitting participation in planned study visits (including planning to move far from their clinical provider's office within the first 4-months of the study (i.e., cannot attend in-office visits) or take...
- inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (greater than mild cognitive impairment as per TICS),
- substance abuse,
- significant hearing loss (unable to hear communication by phone or via videoconferencing),
- significant medical condition likely to limit participation or lifespan,
- individuals who require other types of LVR training or intervention (e.g., psychosocial).
- For Bluetooth low energy beacon sensors, exclusion would occur if their magnifier device has features that would not work in conjunction with the beacon sensors: (1) hands-free and do not have a place where the...
The study team makes the final eligibility decision.
Where it's taking place
- Fullerton, California, United States
- Grass Valley, California, United States
- Los Angeles, California, United States
- San Francisco, California, United States
- Santa Monica, California, United States
- Boston, Massachusetts, United States
- Brockton, Massachusetts, United States
- Midland, Michigan, United States
- Omaha, Nebraska, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fullerton, California, United States; Grass Valley, California, United States; Los Angeles, California, United States; San Francisco, California, United States; Santa Monica, California, United States; Boston, Massachusetts, United States and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.